Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
2876
Trueblue
TBI
$311M
| $2.2M | ﹤0.01% |
91,586
+26,898
| +42% | +$614K |
|
2877
Universal Corp
UVV
$1.27B
| $2.2M | ﹤0.01% |
38,541
+11,041
| +40% | +$596K |
|
|
ARGO
2878
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.2M | ﹤0.01% |
33,418
+15,961
| +91% | +$1.04M |
|
2879
CALL
Chubb
CB
$135B
| $2.19M | ﹤0.01% |
14,100
-28,600
| -67% | -$4.38M |
|
2880
MaxLinear
MXL
$6.8B
| $2.19M | ﹤0.01% |
103,407
+20,515
| +25% | +$426K |
|
2881
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
| $2.19M | ﹤0.01% |
47,209
-3,900
| -8% | -$178K |
|
2882
Archrock
AROC
$5.8B
| $2.18M | ﹤0.01% |
217,164
-11,730
| -5% | -$109K |
|
2883
Editas Medicine
EDIT
$442M
| $2.18M | ﹤0.01% |
73,638
+18,260
| +33% | +$456K |
|
2884
PUT
AGNC Investment
AGNC
$12.9B
| $2.17M | ﹤0.01% |
123,000
-25,200
| -17% | -$429K |
|
2885
Ovintiv
OVV
$16.4B
| $2.17M | ﹤0.01% |
92,811
+43,344
| +88% | +$928K |
|
2886
Chefs' Warehouse
CHEF
$4.5B
| $2.17M | ﹤0.01% |
57,003
+27,874
| +96% | +$1.01M |
|
2887
Cinemark Holdings
CNK
$4.32B
| $2.17M | ﹤0.01% |
64,159
+22,997
| +56% | +$813K |
|
2888
Wolfspeed
WOLF
$1.71B
| $2.17M | ﹤0.01% |
47,053
-59,267
| -56% | -$2.77M |
|
2889
PUT
Archer Daniels Midland
ADM
$36.9B
| $2.17M | ﹤0.01% |
46,800
-10,700
| -19% | -$456K |
|
2890
Argan
AGX
$8.37B
| $2.17M | ﹤0.01% |
54,005
+42,631
| +375% | +$1.64M |
|
2891
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
| $2.17M | ﹤0.01% |
47,400
| – | – |
|
|
BITA
2892
CALL
DELISTED
Bitauto Holdings Limited
BITA
| $2.16M | ﹤0.01% |
145,500
+4,700
| +3% | +$71K |
|
|
WAIR
2893
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $2.16M | ﹤0.01% |
195,856
-55,621
| -22% | -$612K |
|
|
MNTV
2894
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.16M | ﹤0.01% |
120,687
+65,267
| +118% | +$1.15M |
|
2895
First Commonwealth Financial
FCF
$2.17B
| $2.15M | ﹤0.01% |
148,390
+46,525
| +46% | +$653K |
|
2896
Clearway Energy Class C
CWEN
$6.7B
| $2.15M | ﹤0.01% |
107,870
+28,559
| +36% | +$553K |
|
|
VBTX
2897
DELISTED
Veritex Holdings
VBTX
| $2.15M | ﹤0.01% |
73,736
+9,183
| +14% | +$236K |
|
2898
Inogen
INGN
$164M
| $2.14M | ﹤0.01% |
31,371
-10,943
| -26% | -$686K |
|
|
AHRT
2899
AH Realty Trust
AHRT
$517M
| $2.14M | ﹤0.01% |
116,749
-6,123
| -5% | -$111K |
|
2900
Scholastic
SCHL
$792M
| $2.14M | ﹤0.01% |
55,633
+15,357
| +38% | +$579K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.